ClinicalTrials.Veeva

Menu

Contrast Sensitivity in Glaucoma

U

University of Erlangen-Nürnberg

Status

Unknown

Conditions

Primary Open Angle Glaucoma
Secondary Open Angle Glaucoma Due to PEX

Study type

Observational

Funder types

Other

Identifiers

NCT00947869
DFG-SFB539-H

Details and patient eligibility

About

The primary aim of the Erlangen´s Glaucoma Contrast Sensitivity-Study (EGCS-Study) is the evaluation of the diagnostic and prognostic validity of a diagnostic procedure, measuring contrast sensitivity. No therapeutic studies are performed.

Enrollment

30 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

  • Patients: Primary open angle glaucoma, secondary open angle glaucoma due to PEX
  • Healthy volunteers (for reliability analysis)

Inclusion Criteria:

  • Age > 18
  • Best corrected visual acuity 0.8 or better
  • European

Exclusion Criteria:

  • eye diseases: Infantile glaucoma, angle glaucoma, secondary open angle glaucoma, wich are not due to PEX, diseases involving retina, condition after ophthalmological operations or trauma, cataract, diseases concerning the refractive system, age-related macular degeneration, diabetic retinopathy, optic neuropathy (MS, neuritis), amblyopia
  • Any neurological diseases
  • Systemic diseases with potentially ocular involvement (e.g., diabetes mellitus)
  • Systemic drugs with potentially ocular involvement
  • ocular drugs

Trial contacts and locations

1

Loading...

Central trial contact

Anselm G Juenemann, Prof.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems